Trial Profile
Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal Platelets
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Apr 2019
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- Acronyms REVSTARTS
- 24 Oct 2018 New trial record
- 17 Oct 2018 Results published in the Thrombosis and Haemostasis